CopyMark Law Group
4.9/5
Drawing for METATRON

USPTO serial 90790908

METATRON

Reviewed by CopyMark Law Group

Reg. 7819363Status 700Registered
Filing date
Status date
Registration date
Jun 3, 2025
Examiner
GAGLIARDI, JEANINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with METATRON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charlene Azema

Charlene Azema KNOBBE MARTENS OLSON & BEAR LLP2040 MAIN STREET, 14 FLOORKNOBBE, MARTENS, OLSON & BEAR, LLPIRVINE, CA 92614

Goods and services

ClassDescriptionStatusFirst use
010Medical device, namely, diagnostic biofeedback apparatus in the nature of medical biofeedback sensors; Medical diagnostic apparatus for the detection of disease, namely, medical diagnostic apparatus for detecting pathologies at early stages, blood cell abnormalities, tissue abnormalities, organ function abnormalities, and viral, helminth, bacterial, fungal and other pathogenic infections; Medical diagnostic apparatus for the detection of blood cell abnormalities, tissue abnormalities, and organ function abnormalities; medical imaging apparatus; medical imaging apparatus for digital three-dimensional organ and tissue modeling; medical diagnostic instrument for analysis of body fluids and cell frequency; medical products, namely, biofeedback sensors; medical diagnostic apparatus for testing of tissue and cell destruction; medical diagnostic apparatus for impulse and resonance detection; medical diagnostic apparatus for detecting viral, helminth, bacterial, fungal and other pathogenic infections; medical diagnostic apparatus for the detection of pathologies at early stages, namely, infectious diseases and cancers; medical apparatus for prevention of development of disease, namely, medical apparatus for the early detection of infections, cell abnormalities and cancers; medical diagnostic instrument using bioresonance, namely, imaging apparatus for medical purposes; medical apparatus for treatment of muscular structural imbalance; medical apparatus for diagnostic and medical purposes, namely, electromagnetic resonance imaging; medical imaging apparatus with embedded operating system software; medical device, namely, biofeedback sensors that transmit waves through the body to test body function, interpret body and organ health, assess overall physiological functional health, and detect abnormalities, for medical, diagnostic and therapeutic purposes; medical device, namely, neurofeedback device that transmits waves through the brain to test body function, interpret body and organ health, assess overall physiological functional health and psychoemotional health, and detect abnormalities, for medical, diagnostic and therapeutic purposes; medical device, namely, bioresonance sensors that transmit waves through the body to test body function, interpret body and organ health, assess overall physiological functional health and psychoemotional health, and detect abnormalities, for medical, diagnostic and therapeutic purposes; medical device, namely, diagnostic biofeedback hardware in the nature of sensors for evaluating the psycho-physiological condition of a patient on the whole, namely, blood pressure, lung capacity, cardiac output, brain activity, and bodily reflexes, and diagnosing of many illnesses and progressing states; medical device, namely, diagnostic hardware for screening diagnostics of the functional status of human organs and systems; medical device, namely, diagnostic hardware for determining the probabilistic localization of functional change locuses and for locating the epicenter of the disease process for medical diagnostic and treatment purposes; medical device, namely, diagnostic hardware for assessing dynamics of dysfunctional changes in a human body and for assessing the bettering or worsening condition of patient; medical device, namely, diagnostic hardware for assessing the basic parameters of a biosystem homeostasis for medical diagnostic and treatment purposes; Medical device for the performance of informational therapy which represents the effect on an organism of a combination of various modulated oscillations emitted by the device, namely, audio oscillators for detecting toxins and pathogens in the body for medical diagnostic purposes; Medical device for the performance of Lithotherapy which transmits the spectral characteristics of the selected mineral; Medical device for the performance of Phytotherapy which transmits the spectral characteristics of the selected herb; Medical therapeutic device for the performance of psycho-wave correction which is used for psychotherapeutic disorders correction by means of flower essences' spectrum characteristics; Medical therapeutic device for the transmission of a wave function that depresses the wave function of pathological infectious diseases, resulting in a decline of the level of the pathological organism's adaptive responses; embedded software, sold as a component of medical devices, namely, biofeedback sensors and medical apparatus for monitoring vital signs of patients that test and analyze body function, interpret body and organ health, assess overall physiological functional health and psychoemotional health, and detect physiological abnormalitiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 3, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 3, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 13, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 13, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 13, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 13, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 13, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 13, 2025SNEASU-EXAMINER'S AMENDMENT WRITTEN—
May 5, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 7, 2024IUAFUSE AMENDMENT FILED—
Nov 7, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 7, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 6, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 6, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 6, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 6, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 10, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 1, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 1, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jun 1, 2023CNSLSUSPENSION LETTER WRITTEN—
May 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2023DOCKASSIGNED TO EXAMINER—
Oct 20, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2022DOCKASSIGNED TO EXAMINER—
Sep 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance